GlobeNewswire Inc | Jan 5, 2022 09:00AM EST

January 05, 2022

WOBURN, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc.(Nasdaq: NURO) announced today thatShai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the H.C. Wainwright BioConnect Conference to be held virtually on January 10-13, 2022. Dr. Gozanis video presentation will be available on-demand for 90 days starting onMonday, January 10, 2022at7:00 A.M. (ET). It may be accessed here and also on the NeuroMetrix, Inc. Investor Relations page at www.NeuroMetrix.com. Dr. Gozani will highlight the Company's product portfolio, growth initiatives and outlook for 2022.

AboutNeuroMetrix

NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The Company has three commercial products. DPNCheck is a diagnostic device that provides rapid, point-of-care detection of peripheral neuropathies. ADVANCE is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of focal neuropathies. Quell is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. For more information, visit www.NeuroMetrix.com/.

NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief Financial Officerneurometrix.ir@neurometrix.com

Source:NeuroMetrix, Inc.